Steve Schonfeld’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Steve Schonfeld's BMY Position: Q2 2026 in Review
Steve Schonfeld reduced its Bristol-Myers Squibb (BMY) stake by 94% in Q2 2026, selling an estimated $8.41M and leaving 8,937 shares worth $214K. The position accounts for ﹤0.01% of the portfolio, ranked #2164.
Steve Schonfeld first reported a position in BMY in Q1 2016 and has held it in 37 quarters since. The position peaked at $52.9M in Q3 2025. 2,506 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Steve Schonfeld held 8,937 shares of Bristol-Myers Squibb worth $214K as of Q2 2026.
- Steve Schonfeld sold 146,481 Bristol-Myers Squibb shares in Q2 2026, an estimated $8.41M.
- Bristol-Myers Squibb made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #2164 holding.
- Steve Schonfeld first reported a position in Bristol-Myers Squibb in Q1 2016 and has held it in 37 quarters since.
- Steve Schonfeld's Bristol-Myers Squibb position peaked at $52.9M in Q3 2025.
- 2,506 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.